Multicenter Registration Study on Allergic Bronchopulmonary Aspergillosis
NCT ID: NCT06645210
Last Updated: 2024-10-16
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
300 participants
OBSERVATIONAL
2024-10-15
2026-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Pathogenesis and Inflammatory Phenotype of Allergic Bronchopulmonary Aspergillosis
NCT07040332
Effects of Environmental Fungal Exposure on Bronchial Asthma, ABPA and Bronchiectasis
NCT07313904
Interest of IgE Directed Against Recombinant Antigens of Aspergillus Fumigatus in the Diagnosis of Allergic Bronchopulmonary Aspergillosis (ABPA)
NCT07055230
Cytokine Profile of Allergic Bronchopulmonary Aspergillosis
NCT03643185
Protocol TARC-ABPA
NCT01710930
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
85 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
First Affiliated Hospital of Guangxi Medical University
OTHER
Guangzhou Institute of Respiratory Disease
OTHER
Tongji Hospital
OTHER
Nanfang Hospital, Southern Medical University
OTHER
The First Affiliated Hospital with Nanjing Medical University
OTHER
Qianfoshan Hospital
OTHER
The First Affiliated Hospital of Shanxi Medical University
OTHER
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
OTHER
West China Hospital
OTHER
Second Affiliated Hospital of Xi'an Jiaotong University
OTHER
Second Affiliated Hospital, School of Medicine, Zhejiang University
OTHER
Xiangya Hospital of Central South University
OTHER
Peking Union Medical College Hospital
OTHER
Ruijin Hospital
OTHER
Peking University Third Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Sun Yongchang
Prof
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Peking University Third Hospital
Beijing, Beijing Municipality, China
Countries
Review the countries where the study has at least one active or historical site.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
M2024692
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.